{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:58:07Z","timestamp":1791176287601,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ijpharm.2011.10.034","type":"journal-article","created":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T19:44:59Z","timestamp":1319571899000},"page":"356-363","source":"Crossref","is-referenced-by-count":60,"title":["Optimization of rapamycin-loaded acetalated dextran microparticles for immunosuppression"],"prefix":"10.1016","volume":"422","author":[{"given":"Kevin J.","family":"Kauffman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Kanthamneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha A.","family":"Meenach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C.","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Bachelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy M.","family":"Ainslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2011.10.034_bib0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/pi.1697","article-title":"Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]","volume":"54","author":"Alexis","year":"2005","journal-title":"Polym. Int."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1517\/17425247.5.6.615","article-title":"Analysis of initial burst in PLGA microparticles","volume":"5","author":"Allison","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0015","doi-asserted-by":"crossref","first-page":"10494","DOI":"10.1021\/ja803947s","article-title":"Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications","volume":"130","author":"Bachelder","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0020","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1021\/mp900311x","article-title":"In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants","volume":"7","author":"Bachelder","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0025","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1084\/jem.20011629","article-title":"In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines","volume":"195","author":"Barrat","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0030","doi-asserted-by":"crossref","first-page":"10360","DOI":"10.1021\/ja903984s","article-title":"Chemoselective ligation in the functionalization of polysaccharide-based particles","volume":"131","author":"Beaudette","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2567.2008.02824.x","article-title":"Dexamethasone transforms lipopolysaccharide-stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin-10 production in T cells","volume":"125","author":"Bosma","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0040","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1073\/pnas.0901592106","article-title":"Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy","volume":"106","author":"Broaders","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0045","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1002\/eji.200939052","article-title":"Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells","volume":"39","author":"Cong","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function","volume":"82","author":"Dr\u00f6ge","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0055","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2165\/00003495-200262060-00003","article-title":"Newer immunosuppresive drugs: Their potential role in rheumatoid arthritis therapy","volume":"62","author":"Drosos","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijpharm.2004.04.003","article-title":"Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro","volume":"279","author":"Fernandez-Carballido","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-3-540-71029-5_10","article-title":"Use of rapamycin in the induction of tolerogenic dendritic cells","author":"Fischer","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","article-title":"Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model","volume":"298","author":"Foged","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1023\/A:1014474414097","article-title":"Targeting vaccines to dendritic cells","volume":"19","author":"Foged","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0080","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1006\/bbrc.2000.2490","article-title":"Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs","volume":"270","author":"Griffin","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0085","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/jbm.a.31373","article-title":"Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells","volume":"84","author":"Haddadi","year":"2008","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0220","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s11095-011-0459-9","article-title":"Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles","volume":"28","author":"Hamdy","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0095","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1359-0286(02)00117-1","article-title":"Biodegradable nanoparticles for drug delivery and targeting","volume":"6","author":"Hans","year":"2002","journal-title":"Curr. Opin. Solid State Mater."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0100","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(02)12023-X","article-title":"Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial","volume":"360","author":"Hartung","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jconrel.2007.01.013","article-title":"Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages","volume":"119","author":"Hirota","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2008.10.011","article-title":"Delivery of rapamycin to dendritic cells using degradable microparticles","volume":"133","author":"Jhunjhunwala","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0939-6411(00)00079-5","article-title":"Revisiting PLA\/PLGA microspheres: an analysis of their potential in parenteral vaccination","volume":"50","author":"Johansen","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0120","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/S0041-1345(03)00353-1","article-title":"Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to cyclosporine-based immunosuppressive regimens in renal transplantation","volume":"35","author":"Kahan","year":"2003","journal-title":"Transplant Proc."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0125","series-title":"Immunosuppressive Agents. Immunopharmacology","author":"Khan","year":"2009"},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jbm.a.32971","article-title":"Macrophage and dendritic cell phenotypic diversity in the context of biomaterials","volume":"96","author":"Kou","year":"2011","journal-title":"Biomed. Mater. Res. A"},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0135","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/eji.200324174","article-title":"Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses","volume":"34","author":"Litjens","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2133.2005.07002.x","article-title":"Effects of monomethylfumarate on dendritic cell differentiation","volume":"154","author":"Litjens","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0145","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0142-9612(00)00047-8","article-title":"In vitro and in vivo degradation of porous poly(dl-lactic-co-glycolic acid) foams","volume":"21","author":"Lu","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.smim.2008.07.007","article-title":"Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophages","volume":"21","author":"Manicassamy","year":"2009","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0155","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2006.10.036","article-title":"Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres","volume":"334","author":"Mao","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0165","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jconrel.2010.05.032","article-title":"Biomaterial adjuvant effect is attenuated by anti-inflammatory drug delivery or material selection","volume":"146","author":"Norton","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0170","series-title":"Fundamental Immunology","author":"Paul","year":"1994"},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","article-title":"Rapamycin in transplantation: a review of the evidence","volume":"59","author":"Saunders","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5173(00)00617-7","article-title":"Solubilization of rapamycin","volume":"213","author":"Simamora","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0168-3659(96)01484-8","article-title":"Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery","volume":"43","author":"Song","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0190","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.4049\/jimmunol.178.11.7018","article-title":"Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance","volume":"178","author":"Turnquist","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2007.04.022","article-title":"Release profiles in drug-eluting stents: issues and uncertainties","volume":"120","author":"Venkatraman","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0200","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/ibd.20934","article-title":"Retinoic acid contributes to the induction of IL-12-hypoproducing dendritic cells","volume":"15","author":"Wada","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0205","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0378-5173(02)00548-3","article-title":"Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles","volume":"250","author":"Xu","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02980037","article-title":"Control of encapsulation efficiency and initial burst in polymeric microparticle systems","volume":"27","author":"Yeo","year":"2004","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.10.034_bib0215","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1523-1747.2001.01159.x","article-title":"Inhibition of dendritic cell differentiation by fumaric acid esters","volume":"116","author":"Zhu","year":"2001","journal-title":"J. Invest. Dermatol."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311009732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311009732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T06:24:31Z","timestamp":1543472671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517311009732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":43,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0378517311009732"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2011.10.034","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}